<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An association of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome with antibodies directed against either <z:chebi fb="1" ids="16247">phospholipids</z:chebi> or plasma proteins strongly suggest that <z:mp ids='MP_0002459'>B-cell dysfunction</z:mp> may be involved in its pathogenesis </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> syndrome with autoimmune cytopenias shows a poor response rate to conventional treatment with <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, glucocorticosteroids, <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi>, intravenous immunoglobulin or plasmapheresis </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of life-threatening <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome with <z:e sem="disease" ids="C0272126" disease_type="Disease or Syndrome" abbrv="">Evans syndrome</z:e> receiving successful multimodal treatment including anti-CD20 monoclonal antibody rituximab with long-term follow-up </plain></SENT>
</text></document>